deuterium has been researched along with trimethyloxamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bolen, DW; Qu, Y | 1 |
| Christians, U; Serkova, NJ | 1 |
| Blinco, JP; Bottle, SE; Hosokawa, K; Khan, N; Micallef, AS; Swartz, HM | 1 |
| Cuellar, KA; Hammer, NI; Magers, DH; Munroe, KL | 1 |
| Donahue, L; Hazen, JE; Hazen, SL; Levison, BS; Li, XM; Wang, Z | 1 |
| Hennig, B; Hoffman, JB; Morris, AJ; Perkins, JT; Petriello, MC; Sunkara, M; Wahlang, B | 1 |
| Bender, E; Caudill, MA; Cho, CE; King, JH; Malysheva, OV; Taesuwan, S; Thalacker-Mercer, AE; Yan, J | 1 |
| Kusama, T; Miura, T; Mizuno, S; Shimizu, M; Suemizu, H; Uehara, S; Yamazaki, H | 1 |
| Bernhard, W; Böckmann, KA; Franz, AR; Minarski, M; Poets, CF; Shunova, A; Wiechers, C | 1 |
1 trial(s) available for deuterium and trimethyloxamine
| Article | Year |
|---|---|
Different choline supplement metabolism in adults using deuterium labelling.
Topics: Adult; Betaine; Choline; Cross-Over Studies; Deuterium; Fatty Acids; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Phosphatidylcholines; Phosphorylcholine; Prospective Studies | 2023 |
8 other study(ies) available for deuterium and trimethyloxamine
| Article | Year |
|---|---|
Hydrogen exchange kinetics of RNase A and the urea:TMAO paradigm.
Topics: Adaptation, Physiological; Binding Sites; Deuterium; Hydrogen; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Methylamines; Protein Denaturation; Ribonuclease, Pancreatic; Thermodynamics; Urea | 2003 |
Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood.
Topics: Animals; Biomarkers; Blood Glucose; Cholesterol; Creatine; Creatinine; Cyclosporine; Deuterium; Drug Interactions; Drug Monitoring; Everolimus; Glutathione; Hydroxybutyrates; Immunosuppressive Agents; Lactates; Magnetic Resonance Spectroscopy; Methylamines; Rats; Reproducibility of Results; Sirolimus; Time Factors | 2005 |
The evaluation of new and isotopically labeled isoindoline nitroxides and an azaphenalene nitroxide for EPR oximetry.
Topics: Animals; Antineoplastic Agents; CHO Cells; Chromatography, Thin Layer; Clone Cells; Cricetinae; Cricetulus; Cyclic N-Oxides; Deuterium; Electron Spin Resonance Spectroscopy; Indicators and Reagents; Indoles; Isoindoles; Isotope Labeling; Methylamines; Nitrogen Oxides; Nitrogen Radioisotopes; Oximetry; Oxygen; Oxygen Consumption; Trypan Blue | 2011 |
Noncovalent interactions in microsolvated networks of trimethylamine N-oxide.
Topics: Deuterium; Hydrogen Bonding; Methylamines; Models, Theoretical; Solvents; Spectrum Analysis, Raman; Thermodynamics | 2014 |
Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry.
Topics: Adult; Aged; Chromatography, Liquid; Deuterium; Fasting; Female; Humans; Indicator Dilution Techniques; Limit of Detection; Male; Methylamines; Middle Aged; Reference Values; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.
Topics: Administration, Oral; Animals; Atherosclerosis; Biomarkers; Choline; Deuterium; Dietary Fats; Environmental Pollutants; Enzyme Induction; Food-Drug Interactions; Liver; Male; Methylamines; Mice, Inbred C57BL; Oxygenases; Phosphatidylcholines; Polychlorinated Biphenyls; Random Allocation; Up-Regulation | 2016 |
The metabolic fate of isotopically labeled trimethylamine-N-oxide (TMAO) in humans.
Topics: Administration, Oral; Adult; Deuterium; Humans; Male; Methylamines; Middle Aged; Muscle, Skeletal; Oxygenases; Polymorphism, Genetic | 2017 |
Human plasma concentrations of trimethylamine N-oxide extrapolated using pharmacokinetic modeling based on metabolic profiles of deuterium-labeled trimethylamine in humanized-liver mice.
Topics: Administration, Oral; Animals; Atherosclerosis; Deuterium; Hepatocytes; Humans; Methylamines; Mice; Microsomes, Liver; Models, Animal; Models, Biological; Rats; Risk Assessment | 2018 |